News

Best probiotic supplements in the UK for a healthy digestive system - Give your gut a break with our pick of the best ...
† VIMs are made up of 266 amino acid residues with the exception of VIM-7 (265 residues) and VIM-18 (262 residues). VIM-21, -22 and -27 have been assigned in the Lahey Clinic [201], but there ...
noninterventional registry developed to collect real-world data on the use of daptomycin in the treatment of patients with Gram-positive infections. This subgroup analysis evaluated the safety and ...
(Alliance News) - GSK PLC on Friday said its drug Blenrep has received a "positive opinion" from the ... brand name Blenrep, for the treatment of adults with relapsed or refractory multiple ...
has adopted a positive opinion recommending the granting of a conditional marketing authorization for mirdametinib, a MEK inhibitor, for the treatment of symptomatic, inoperable plexiform ...
Durable clinical benefits were observed one year after treatment, including improved cardiac function and significantly enhanced patient quality of life. In 2024, approximately 2.5 million people ...
has adopted a positive opinion recommending the granting of a conditional marketing authorization for mirdametinib, a MEK inhibitor, for the treatment of symptomatic, inoperable plexiform ...
Gyre Therapeutics announced positive results from its Phase 3 trial of Hydronidone, a treatment for liver fibrosis in patients with chronic hepatitis B (CHB), showing a significant regression in ...
CDK 4/6 inhibitors (CDKi) + endocrine therapy (ET) in ER-positive metastatic breast cancer (mBC) patients according ET sensitivity: A systematic review and meta-analysis. This is an ASCO Meeting ...
If you or a loved one has been diagnosed with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer, you may be wondering about the various treatment ...
(Alliance News) - GSK PLC on Friday said its drug Blenrep has received a "positive opinion" from the European Medicines ... brand name Blenrep, for the treatment of adults with relapsed or refractory ...